| scholarly article | Q13442814 |
| P50 | author | Yu Mao | Q91648162 |
| P2093 | author name string | Lixin Dong | |
| Xin Li | |||
| Qiang Zhang | |||
| Chao Wang | |||
| Yimin Wang | |||
| Yanqiu Zhang | |||
| Zhanzhao Fu | |||
| P2860 | cites work | Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes | Q24294847 |
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| The blockade of immune checkpoints in cancer immunotherapy | Q27860852 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| The tumor microenvironment in esophageal cancer | Q28077074 | ||
| PD-1 and its ligands in tolerance and immunity | Q28131650 | ||
| Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
| Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells | Q30587658 | ||
| Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity | Q33186765 | ||
| B10 cell regulation of health and disease | Q33726933 | ||
| Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis | Q34125617 | ||
| Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. | Q34144779 | ||
| Oesophageal carcinoma | Q34325751 | ||
| PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity | Q36821174 | ||
| Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy | Q36829161 | ||
| PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment. | Q36868333 | ||
| Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. | Q37590909 | ||
| CD20+ B cells: the other tumor-infiltrating lymphocytes | Q37801779 | ||
| Exosomes as intercellular signalosomes and pharmacological effectors. | Q37849358 | ||
| Exosome secretion: molecular mechanisms and roles in immune responses | Q37885448 | ||
| Exosomes and their roles in immune regulation and cancer | Q38365943 | ||
| Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. | Q38710173 | ||
| PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. | Q38790070 | ||
| The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients | Q38827388 | ||
| Glioma cell-derived placental growth factor induces regulatory B cells | Q38934778 | ||
| B cell regulation in cancer and anti-tumor immunity. | Q39381508 | ||
| Human tumor-derived exosomes down-modulate NKG2D expression. | Q39980589 | ||
| Natural killer cell-mediated immunosurveillance of human cancer. | Q40059213 | ||
| IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation | Q41049735 | ||
| PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells. | Q42253745 | ||
| Inhibitory effects of B cells on antitumor immunity. | Q44423014 | ||
| IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro | Q51038853 | ||
| Bacterially activated B-cells drive T cell differentiation towards Tr1 through PD-1/PD-L1 expression. | Q52679392 | ||
| Cutting edge: IL-10-producing regulatory B cells in early human pregnancy. | Q54776066 | ||
| A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma. | Q55361204 | ||
| A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma | Q58557941 | ||
| Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2 | Q60193080 | ||
| Mesenchymal Stromal Cell-Derived Exosomes Affect mRNA Expression and Function of B-Lymphocytes | Q60938459 | ||
| Low percentage of CD24hiCD27⁺CD19⁺ B cells decelerates gastric cancer progression in XELOX-treated patients | Q87161872 | ||
| PD-1-expressing B cells suppress CD4+ and CD8+ T cells via PD-1/PD-L1-dependent pathway | Q92242429 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
| P304 | page(s) | 2700-2710 | |
| P577 | publication date | 2019-07-28 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD-1high Breg cells | |
| P478 | volume | 110 |
| Q99565928 | Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors |
| Q93129624 | Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells |
| Q99619165 | Tumor-derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines |
Search more.